James B. Bussel, MD

    James B. Bussel, MD

    Professor Emeritus of Pediatrics, Weill Cornell Medical College
    • What Is the Optimal Treatment of ITP? Tuesday, December 1st, 2020

      In recent years, the number of treatment options available for patients with immune thrombocytopenia (ITP) has expanded. In addition to the classical trio of corticosteroids, intravenous immunoglobulin, and splenectomy, choices now include rituximab, thrombopoietin receptor agonists (TPO-RAs), and the tyrosine kinase inhibitor fostamatinib. However, a lack of randomized clinical trials evaluating the management of ITP [...]